Literature DB >> 27321244

Minimally invasive epicardial implantable cardioverter-defibrillator placement for infants and children: An effective alternative to the transvenous approach.

Andrew E Schneider1, Harold M Burkhart2, Michael J Ackerman3, Joseph A Dearani2, Philip Wackel1, Bryan C Cannon4.   

Abstract

BACKGROUND: Young patients have high rates of implantable cardioverter-defibrillator (ICD) lead fractures and are at risk for venous occlusion or tricuspid regurgitation with transvenous lead placement. Epicardial ICDs have the potential to circumvent complications associated with transvenous ICDs, but the literature on young patients remains limited.
OBJECTIVE: The purpose of this study was to evaluate the results of a minimally invasive epicardial ICD lead placement approach in young patients.
METHODS: A retrospective, institutional review board-approved electronic medical record review of all patients undergoing epicardial ICD placement at our institution from January 2011 to December 2015 was performed.
RESULTS: A total of 46 patients (20 female [43%]; mean age 10.3 years, range 0.7-18.2 years; mean weight 41 ± 21 kg) were identified; 24 (52%) were ≤10 years old. A minithoracotomy was used in 28 patients (61%). All had acceptable defibrillation, right ventricular sensing, and stimulation thresholds. Median follow-up was 2.0 ± 1.3 years (range 0.02-4.5 years). Eight surgical complications occurred in 7 patients (15%), and 8 device-related complications occurred in 6 patients (13%). Fifty-eight appropriate shocks were delivered in 7 patients (15%). Four patients received inappropriate shocks in relation to lead fractures/microfractures. One patient in this cohort who had long QT syndrome type 8 died of a hypoglycemic seizure.
CONCLUSION: Minimally invasive epicardial ICD placement provides an effective, alternative method for implanting an ICD system, particularly in very young patients (<6 years of age) or patients who are concerned about cosmetic appearance. This technique is an acceptable alternative to traditional transvenous ICD placement.
Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epicardial ICD placement; Hypertrophic cardiomyopathy; Implantable cardioverter-defibrillator; Long QT syndrome; Minimally invasive surgical approach

Mesh:

Year:  2016        PMID: 27321244     DOI: 10.1016/j.hrthm.2016.06.024

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  3 in total

1.  Challenging indication of cardioverter defibrillator implantation after sudden cardiac arrest in the very young: a case series of catecholaminergic polymorphic ventricular tachycardia secondary to de novo calmodulin p.Asn98Ser.

Authors:  Alice Maltret; Fatima Azzahrae Benaich; John Rendu; Véronique Fressart; Nathalie Roux-Buisson; Damien Bonnet; Isabelle Denjoy
Journal:  Eur Heart J Case Rep       Date:  2021-10-05

2.  Subcutaneous Implantable Cardioverter Defibrillators for the Prevention of Sudden Cardiac Death: Pediatric Single-Center Experience.

Authors:  Piotr Wieniawski; Michał Buczyński; Marcin Grabowski; Joachim Winter; Bożena Werner
Journal:  Int J Environ Res Public Health       Date:  2022-09-16       Impact factor: 4.614

3.  Multicentre early experience with totally subcutaneous cardioverter-defibrillators in Poland.

Authors:  Krzysztof Kaczmarek; Maciej Kempa; Marcin Grabowski; Mateusz Tajstra; Adam Sokal; Iwona Cygankiewicz; Radosław Zwoliński; Marcin Michalak; Michal Kowara; Szymon Budrejko; Anna Kurek; Jerzy K Wranicz; Grzegorz Raczak; Grzegorz Opolski; Mariusz Gąsior; Oskar Kowalski; Paweł Ptaszyński
Journal:  Arch Med Sci       Date:  2019-05-21       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.